Skip to main content
×
Main navigation
Show — Main navigation
Hide — Main navigation
Home
Related Content
Journal Articles
Videos
Podcasts
About
Topics
Videos
Journal Articles
Accredited
Journal Articles
Journal Articles
Peripheral Artery Disease, the Factor Xa Inhibitor Rivaroxaban, and the Role of the Podiatrist
Journal Articles
Cost-Effectiveness of Critical Limb Ischemia Treatments—Critical Gaps Remain
Journal Articles
VOYAGER PAD: Rivaroxaban Reduces Risk in Symptomatic PAD Post Intervention
Journal Articles
ACC.21: Xarelto (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in PAD Patients After Lower-Extremity Revascularization
Journal Articles
Data From New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of Xarelto (rivaroxaban) Plus Aspirin in Patients With Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
Journal Articles
New Xarelto (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
Journal Articles
Janssen Submits Application to U.S. FDA for New Indication to Expand Use of Xarelto (rivaroxaban) in Patients with Peripheral Artery Disease
Journal Articles
ACC.20/WCC – Hiatt: VOYAGER PAD Subgroup Analysis
Journal Articles
(ACC.20/WCC) VOYAGER PAD – Rivaroxaban Reduces Risk in Symptomatic PAD Post Intervention
Journal Articles
PAD Patient Pathways: Consensus Guidelines
Back to Top